Gentex CorpGNTX
Price$21.95Intrinsic value$34.4757% above price

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $2.6B+13.5% YoYTTM through 30 Jun 2026
Net Income $407.1M+0.6% YoYTTM through 30 Jun 2026
Free Cash Flow $496.7MTTM through 30 Jun 2026

Margins

Current
Gross Margin33.8%
EBITDA Margin23.2%
Operating Margin18.3%
Net Margin15.5%

Returns

15.5%ROE
13.0%ROA
17.9%ROIC

Balance Sheet Health

Debt / Equity0.00x
Current Ratio2.72x
Net Debt-$175Mnet cash position
Cash & Equivalents$233.4M

Quality Metrics

Altman Z-Score8.62
Piotroski F-Score8 / 9
FCF Margin18.9%
Rule of 4020.6
Earnings-Beat Rate75.0%

Multi-Year Trend

Revenue
'19'20'21'22'23'24'25
FY2025: $2.5B
Diluted EPS$1.89TTM
'19'20'21'22'23'24'25
FY2025: $1.74

Dividend

$0.36Per share, FY20261.61%Yield-5.6%5-yr growth

Capital Allocation

R&D Spend$206.8M
Capex Intensity3.7%

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.